CN Stock MarketDetailed Quotes

603963 Dali Pharmaceutical

Watchlist
  • 3.31
  • +0.16+5.08%
Not Open Aug 30 15:00 CST
727.21MMarket Cap-34123P/E (TTM)

Dali Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
Total operating revenue
-53.99%27.41M
-58.47%15.32M
-34.06%87.27M
-27.06%73.27M
-14.51%59.57M
-7.36%36.89M
-22.83%132.34M
-22.21%100.46M
-24.30%69.68M
-18.74%39.82M
Operating revenue
-53.99%27.41M
-58.47%15.32M
-34.06%87.27M
-27.06%73.27M
-14.51%59.57M
-7.36%36.89M
-22.83%132.34M
-22.21%100.46M
-24.30%69.68M
-18.74%39.82M
Other operating revenue
98.09%749.67K
----
4,463.09%860.47K
----
3,913.76%378.44K
----
-15.38%18.86K
----
0.00%9.43K
----
Total operating cost
-42.10%41.22M
-45.71%21.99M
-27.32%113.27M
-22.14%90.85M
-11.88%71.2M
-8.34%40.51M
-15.85%155.84M
-16.27%116.68M
-16.89%80.79M
-12.97%44.2M
Operating cost
-16.09%24.49M
-16.94%13.53M
-11.79%50.97M
-13.01%37.96M
-5.71%29.19M
26.83%16.29M
25.78%57.79M
33.22%43.63M
36.16%30.95M
8.01%12.85M
Operating tax surcharges
-27.52%1.26M
-31.18%615.91K
2.82%3.21M
12.07%2.38M
42.92%1.74M
19.95%894.9K
-12.57%3.12M
-21.04%2.12M
-32.70%1.22M
-21.91%746.07K
Operating expense
-78.76%6.44M
-82.87%3.22M
-46.02%39.78M
-34.31%36.45M
-21.40%30.33M
-14.76%18.78M
-26.89%73.69M
-27.19%55.49M
-29.34%38.58M
-23.38%22.03M
Administration expense
-7.84%7.77M
-5.88%3.68M
-13.25%16.86M
-15.04%12.13M
-10.96%8.43M
-52.38%3.91M
-41.82%19.43M
-46.56%14.28M
-46.10%9.46M
-8.13%8.22M
Financial expense
-49.35%471K
-48.66%246.08K
80.61%1.61M
250.24%1.27M
3,293.76%929.97K
5,764.75%479.31K
1,823.74%889.65K
847.33%362.71K
165.17%27.4K
117.10%8.17K
-Interest expense (Financial expense)
-48.17%518.5K
-48.54%269.29K
58.50%1.71M
168.11%1.37M
681.20%1M
722.18%523.32K
335.85%1.08M
524.61%509.32K
135.54%128.04K
--63.65K
-Interest Income (Financial expense)
31.56%-54.69K
50.92%-25.7K
43.65%-117.68K
29.63%-107.99K
28.55%-79.91K
13.63%-52.37K
8.59%-208.85K
-1.20%-153.45K
0.59%-111.83K
-8.96%-60.63K
Research and development
35.34%789.82K
360.18%699.46K
-9.44%839.52K
-16.38%662.56K
7.83%583.58K
-56.27%152K
-35.66%926.99K
-23.07%792.38K
0.77%541.2K
21.51%347.58K
Credit Impairment Loss
-154.27%-33.86K
90.21%-13.07K
-153.14%-144.97K
-67.94%178.46K
21.83%62.39K
-1,272.94%-133.52K
359.65%272.84K
600.30%556.74K
-71.14%51.21K
-86.31%11.38K
Asset Impairment Loss
---98.27K
----
1,681.21%3.6M
----
----
---2.74K
100.64%201.96K
----
----
----
Other net revenue
-35.66%1.93M
-27.88%1.01M
41.47%8.96M
-21.40%4.38M
-11.42%3M
-13.52%1.4M
124.26%6.33M
6.91%5.57M
-14.92%3.39M
-21.88%1.62M
Fair value change income
-35.20%1.62M
-36.02%854.42K
-10.12%4.68M
-20.88%3.58M
-12.93%2.5M
-14.63%1.34M
1,812.46%5.21M
200.60%4.53M
1,628.85%2.87M
-19.34%1.56M
Invest income
4.56%336.85K
4.87%115.8K
17.01%514.66K
37.59%424.73K
4.37%322.17K
--110.42K
-91.98%439.85K
-91.00%308.68K
-92.12%308.68K
----
Asset deal income
-45.42%28.63K
----
--52.46K
--52.46K
--52.46K
--52.46K
----
----
----
----
Other revenue
23.84%75.2K
36.84%52.99K
22.93%262.5K
-20.75%138.72K
-60.32%60.72K
-12.34%38.72K
-50.49%213.54K
-54.42%175.04K
109.59%153.04K
-13.42%44.18K
Operating profit
-37.77%-11.88M
-154.59%-5.66M
0.76%-17.04M
-23.91%-13.2M
-11.72%-8.62M
19.48%-2.22M
56.87%-17.17M
-113.07%-10.65M
-556.16%-7.72M
-1,069.60%-2.76M
Add:Non operating Income
281.65%70.78K
283.06%35.35K
-90.10%26.61K
-38.12%23.91K
-33.78%18.54K
3.58%9.23K
420.76%268.83K
113.61%38.64K
207.84%28.01K
107.95%8.91K
Less:Non operating expense
-99.95%179.48
-99.83%179.48
258.82%359.57K
258.55%358.8K
258.55%358.8K
--106.73K
-94.55%100.21K
-90.64%100.07K
-8.08%100.07K
----
Total profit
-31.76%-11.81M
-142.38%-5.63M
-2.18%-17.37M
-26.32%-13.53M
-15.06%-8.96M
15.67%-2.32M
59.13%-17M
-77.09%-10.71M
-510.51%-7.79M
-1,082.25%-2.75M
Less:Income tax cost
-81.12%343.24K
-209.69%-252.29K
278.31%2.66M
143.13%1.85M
159.91%1.82M
-49.38%230K
135.68%703.97K
887.50%762.71K
778.15%699.44K
401.07%454.35K
Net profit
FPtoL-12.15M
FPtoL-5.38M
FPtoL-20.03M
FPtoL-15.39M
FPtoL-10.78M
FPtoL-2.55M
FPtoL-17.7M
FPtoL-11.48M
FPtoL-8.49M
SL-3.21M
Net profit from continuing operation
-12.72%-12.15M
-110.65%-5.38M
-13.16%-20.03M
-34.08%-15.39M
-26.99%-10.78M
20.45%-2.55M
57.74%-17.7M
-92.78%-11.48M
-623.82%-8.49M
-1,791.60%-3.21M
Net profit of parent company owners
-12.72%-12.15M
-110.65%-5.38M
-13.16%-20.03M
-34.08%-15.39M
-26.99%-10.78M
20.45%-2.55M
57.74%-17.7M
-92.78%-11.48M
-623.82%-8.49M
-1,791.60%-3.21M
Earning per share
Basic earning per share
-12.63%-0.0553
-111.21%-0.0245
-12.50%-0.09
-34.10%-0.07
-27.20%-0.0491
20.55%-0.0116
57.89%-0.08
-92.62%-0.0522
-628.30%-0.0386
-1,722.22%-0.0146
Diluted earning per share
-12.63%-0.0553
-111.21%-0.0245
-12.50%-0.09
-34.10%-0.07
-27.20%-0.0491
20.55%-0.0116
57.89%-0.08
-92.62%-0.0522
-628.30%-0.0386
-1,722.22%-0.0146
Other composite income
Total composite income
-12.72%-12.15M
-110.65%-5.38M
-13.16%-20.03M
-34.08%-15.39M
-26.99%-10.78M
20.45%-2.55M
57.74%-17.7M
-92.78%-11.48M
-623.82%-8.49M
-1,791.60%-3.21M
Total composite income of parent company owners
-12.72%-12.15M
-110.65%-5.38M
-13.16%-20.03M
-34.08%-15.39M
-26.99%-10.78M
20.45%-2.55M
57.74%-17.7M
-92.78%-11.48M
-623.82%-8.49M
-1,791.60%-3.21M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Auditor
--
--
Shinnaganaka & Chung Certified Public Accountants (Special General Partnership)
--
--
--
Shinnaganaka & Chung Certified Public Accountants (Special General Partnership)
--
--
--
(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022
Total operating revenue -53.99%27.41M-58.47%15.32M-34.06%87.27M-27.06%73.27M-14.51%59.57M-7.36%36.89M-22.83%132.34M-22.21%100.46M-24.30%69.68M-18.74%39.82M
Operating revenue -53.99%27.41M-58.47%15.32M-34.06%87.27M-27.06%73.27M-14.51%59.57M-7.36%36.89M-22.83%132.34M-22.21%100.46M-24.30%69.68M-18.74%39.82M
Other operating revenue 98.09%749.67K----4,463.09%860.47K----3,913.76%378.44K-----15.38%18.86K----0.00%9.43K----
Total operating cost -42.10%41.22M-45.71%21.99M-27.32%113.27M-22.14%90.85M-11.88%71.2M-8.34%40.51M-15.85%155.84M-16.27%116.68M-16.89%80.79M-12.97%44.2M
Operating cost -16.09%24.49M-16.94%13.53M-11.79%50.97M-13.01%37.96M-5.71%29.19M26.83%16.29M25.78%57.79M33.22%43.63M36.16%30.95M8.01%12.85M
Operating tax surcharges -27.52%1.26M-31.18%615.91K2.82%3.21M12.07%2.38M42.92%1.74M19.95%894.9K-12.57%3.12M-21.04%2.12M-32.70%1.22M-21.91%746.07K
Operating expense -78.76%6.44M-82.87%3.22M-46.02%39.78M-34.31%36.45M-21.40%30.33M-14.76%18.78M-26.89%73.69M-27.19%55.49M-29.34%38.58M-23.38%22.03M
Administration expense -7.84%7.77M-5.88%3.68M-13.25%16.86M-15.04%12.13M-10.96%8.43M-52.38%3.91M-41.82%19.43M-46.56%14.28M-46.10%9.46M-8.13%8.22M
Financial expense -49.35%471K-48.66%246.08K80.61%1.61M250.24%1.27M3,293.76%929.97K5,764.75%479.31K1,823.74%889.65K847.33%362.71K165.17%27.4K117.10%8.17K
-Interest expense (Financial expense) -48.17%518.5K-48.54%269.29K58.50%1.71M168.11%1.37M681.20%1M722.18%523.32K335.85%1.08M524.61%509.32K135.54%128.04K--63.65K
-Interest Income (Financial expense) 31.56%-54.69K50.92%-25.7K43.65%-117.68K29.63%-107.99K28.55%-79.91K13.63%-52.37K8.59%-208.85K-1.20%-153.45K0.59%-111.83K-8.96%-60.63K
Research and development 35.34%789.82K360.18%699.46K-9.44%839.52K-16.38%662.56K7.83%583.58K-56.27%152K-35.66%926.99K-23.07%792.38K0.77%541.2K21.51%347.58K
Credit Impairment Loss -154.27%-33.86K90.21%-13.07K-153.14%-144.97K-67.94%178.46K21.83%62.39K-1,272.94%-133.52K359.65%272.84K600.30%556.74K-71.14%51.21K-86.31%11.38K
Asset Impairment Loss ---98.27K----1,681.21%3.6M-----------2.74K100.64%201.96K------------
Other net revenue -35.66%1.93M-27.88%1.01M41.47%8.96M-21.40%4.38M-11.42%3M-13.52%1.4M124.26%6.33M6.91%5.57M-14.92%3.39M-21.88%1.62M
Fair value change income -35.20%1.62M-36.02%854.42K-10.12%4.68M-20.88%3.58M-12.93%2.5M-14.63%1.34M1,812.46%5.21M200.60%4.53M1,628.85%2.87M-19.34%1.56M
Invest income 4.56%336.85K4.87%115.8K17.01%514.66K37.59%424.73K4.37%322.17K--110.42K-91.98%439.85K-91.00%308.68K-92.12%308.68K----
Asset deal income -45.42%28.63K------52.46K--52.46K--52.46K--52.46K----------------
Other revenue 23.84%75.2K36.84%52.99K22.93%262.5K-20.75%138.72K-60.32%60.72K-12.34%38.72K-50.49%213.54K-54.42%175.04K109.59%153.04K-13.42%44.18K
Operating profit -37.77%-11.88M-154.59%-5.66M0.76%-17.04M-23.91%-13.2M-11.72%-8.62M19.48%-2.22M56.87%-17.17M-113.07%-10.65M-556.16%-7.72M-1,069.60%-2.76M
Add:Non operating Income 281.65%70.78K283.06%35.35K-90.10%26.61K-38.12%23.91K-33.78%18.54K3.58%9.23K420.76%268.83K113.61%38.64K207.84%28.01K107.95%8.91K
Less:Non operating expense -99.95%179.48-99.83%179.48258.82%359.57K258.55%358.8K258.55%358.8K--106.73K-94.55%100.21K-90.64%100.07K-8.08%100.07K----
Total profit -31.76%-11.81M-142.38%-5.63M-2.18%-17.37M-26.32%-13.53M-15.06%-8.96M15.67%-2.32M59.13%-17M-77.09%-10.71M-510.51%-7.79M-1,082.25%-2.75M
Less:Income tax cost -81.12%343.24K-209.69%-252.29K278.31%2.66M143.13%1.85M159.91%1.82M-49.38%230K135.68%703.97K887.50%762.71K778.15%699.44K401.07%454.35K
Net profit FPtoL-12.15MFPtoL-5.38MFPtoL-20.03MFPtoL-15.39MFPtoL-10.78MFPtoL-2.55MFPtoL-17.7MFPtoL-11.48MFPtoL-8.49MSL-3.21M
Net profit from continuing operation -12.72%-12.15M-110.65%-5.38M-13.16%-20.03M-34.08%-15.39M-26.99%-10.78M20.45%-2.55M57.74%-17.7M-92.78%-11.48M-623.82%-8.49M-1,791.60%-3.21M
Net profit of parent company owners -12.72%-12.15M-110.65%-5.38M-13.16%-20.03M-34.08%-15.39M-26.99%-10.78M20.45%-2.55M57.74%-17.7M-92.78%-11.48M-623.82%-8.49M-1,791.60%-3.21M
Earning per share
Basic earning per share -12.63%-0.0553-111.21%-0.0245-12.50%-0.09-34.10%-0.07-27.20%-0.049120.55%-0.011657.89%-0.08-92.62%-0.0522-628.30%-0.0386-1,722.22%-0.0146
Diluted earning per share -12.63%-0.0553-111.21%-0.0245-12.50%-0.09-34.10%-0.07-27.20%-0.049120.55%-0.011657.89%-0.08-92.62%-0.0522-628.30%-0.0386-1,722.22%-0.0146
Other composite income
Total composite income -12.72%-12.15M-110.65%-5.38M-13.16%-20.03M-34.08%-15.39M-26.99%-10.78M20.45%-2.55M57.74%-17.7M-92.78%-11.48M-623.82%-8.49M-1,791.60%-3.21M
Total composite income of parent company owners -12.72%-12.15M-110.65%-5.38M-13.16%-20.03M-34.08%-15.39M-26.99%-10.78M20.45%-2.55M57.74%-17.7M-92.78%-11.48M-623.82%-8.49M-1,791.60%-3.21M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ----Unqualified opinion------Unqualified opinion------
Auditor ----Shinnaganaka & Chung Certified Public Accountants (Special General Partnership)------Shinnaganaka & Chung Certified Public Accountants (Special General Partnership)------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg